comparemela.com
Home
Live Updates
Creso Pharma Ltds subsidiary Halucenex demonstrates potential of psilocybin to treat PTSD : comparemela.com
Creso Pharma Ltd's subsidiary Halucenex demonstrates potential of psilocybin to treat PTSD
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has received “promising” early results from its wholly owned psychedelics subsidiary Halucenex Life Sciences Inc.'s...
Related Keywords
Australia
,
Australian
,
Creso Pharma
,
Creso Pharma Ltd
,
Halucenex Life Sciences Inc
,
Halucenex Life Sciences
,
Clinical Trial Amendment
,
William Lay
,
Structured Clinical Interview
,
comparemela.com © 2020. All Rights Reserved.